Add BrightSurf on Google Email

Universitat Autonoma de Barcelona


UAB researchers find protein that improves mobility after spinal cord injuries

UAB researchers have identified a protein called IL-37 that suppresses the inflammatory response after spinal cord injuries, minimizing tissue degeneration and functional disabilities. This discovery opens the door to a new treatment for acute spinal cord injuries, which currently has no effective treatment available.

SourceUniversitat Autonoma de Barcelona·JournalProceedings of the National Academy of Sciences·DateJan 22, 2016

Submarine groundwater discharge adds as much nutrients as rivers to the Mediterranean Sea

A new study calculates the magnitude of submarine groundwater discharge into the Mediterranean Sea, revealing it can add as much nutrients as rivers. The annual volume of SGD ranges from 30 to 500 billion cubic meters, with a median nutrient flux comparable to atmospheric deposition and riverine runoff.

SourceUniversitat Autonoma de Barcelona·JournalProceedings of the National Academy of Sciences·DateMar 18, 2015

Renewable energy obtained from wastewater

Researchers at Universitat Autonoma de Barcelona have developed a technology to recover energy from wastewater using MEC, producing hydrogen with high efficiency and low voltage. The system demonstrated excellent results in hydrogen production and energy recovery, opening up potential for industrial-scale development.

SourceUniversitat Autonoma de Barcelona·JournalWater Research·DateFeb 24, 2015

Record quantum entanglement of multiple dimensions

Researchers from Universitat Autonoma de Barcelona have achieved a groundbreaking quantum entanglement with a minimum of 103 dimensions using only two particles. This breakthrough enables the creation of highly complex states that can facilitate experimental development of quantum computers and enhance cryptography security.

SourceUniversitat Autonoma de Barcelona·JournalProceedings of the National Academy of Sciences·DateMar 27, 2014

Gene therapy cures a severe paediatric neurodegenerative disease in animal models

A new gene therapy treatment has been developed to cure Sanfilippo Syndrome type A in animal models by introducing the sulfamidase enzyme into cells, eliminating glycosaminoglican accumulation and associated neuroinflammation. The treatment has shown promising results in mice and dogs, with improved behavior and life expectancy.

SourceUniversitat Autonoma de Barcelona·JournalJournal of Clinical Investigation·DateJul 2, 2013